Post-discharge pharmacotherapy in people with atrial fibrillation hospitalised for acute myocardial infarction: an Australian cohort study 2018-2022.
Claire T DeakinJuliana de Oliveira CostaDavid B BriegerJialing LinAndrea L SchafferMichael R KiddSallie-Anne PearsonMichael O FalsterPublished in: European heart journal. Quality of care & clinical outcomes (2024)
We identified potential gaps in pharmacotherapy, including underuse of recommended therapies at discharge, use of combinations associated with increased bleeding, and P2Y12i use beyond 12 months. Prescribing vigilance across both hospital and community care is required.
Keyphrases
- atrial fibrillation
- acute myocardial infarction
- healthcare
- percutaneous coronary intervention
- smoking cessation
- primary care
- adverse drug
- catheter ablation
- left atrial
- mental health
- oral anticoagulants
- palliative care
- left ventricular
- direct oral anticoagulants
- left atrial appendage
- heart failure
- quality improvement
- pain management
- human health
- acute coronary syndrome
- affordable care act
- climate change
- risk assessment
- chronic pain